Insider plans 25,000-share Rule 144 sale in CFLT (CFLT)

Rhea-AI Filing Summary

A holder associated with CFLT has filed a Rule 144 notice to sell 25,000 shares of common stock through Morgan Stanley Smith Barney LLC on or about 02/13/2026 on NASDAQ, with an aggregate market value of $763,000. These shares were acquired on 02/03/2023 via a distribution from Index Ventures. The notice also reports prior Rule 10b5-1 sales on 12/08/2025, including 32,038 common shares for Michelangelo Volpi for gross proceeds of $953,883.39 and 17,962 common shares for the Volpi-Cupal Family Trust for gross proceeds of $534,791.61.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	763000.00	308661566	02/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/03/2023	Distribution from Index Ventures	Issuer			25000	02/03/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHELANGELO VOLPI 899 W. EVELYN AVENUE MOUNTAIN VIEW CA 94041	Common	12/08/2025	32038	953883.39
10b5-1 Sales for VOLPI-CUPAL FAMILY TRUST U/A DTD 04/05/2000 899 W. EVELYN AVENUE MOUNTAIN VIEW CA 94041	Common	12/08/2025	17962	534791.61

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the latest Form 144 filing for CFLT disclose?

The Form 144 filing discloses an intention to sell 25,000 CFLT common shares under Rule 144. The planned NASDAQ sale, through Morgan Stanley Smith Barney LLC, has an aggregate market value of $763,000 based on the figures reported in the notice.

How many CFLT shares are planned to be sold under this Rule 144 notice?

The filer plans to sell 25,000 shares of CFLT common stock under Rule 144. The planned transaction is routed through Morgan Stanley Smith Barney LLC, with an estimated aggregate market value of $763,000 and an approximate sale date of February 13, 2026.

When were the CFLT shares being sold under Rule 144 originally acquired?

The 25,000 CFLT common shares covered by this Rule 144 notice were acquired on February 3, 2023. They came via a distribution from Index Ventures, with the same date listed as the date of payment and the nature of payment recorded as N/A.

What prior CFLT stock sales are reported in the past three months section?

The filing reports prior sales on December 8, 2025, including 32,038 CFLT common shares for Michelangelo Volpi and 17,962 shares for the Volpi-Cupal Family Trust. These Rule 10b5-1 sales generated gross proceeds of $953,883.39 and $534,791.61, respectively.

Which broker will handle the planned CFLT Rule 144 share sale?

The planned Rule 144 sale of 25,000 CFLT common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, with the sale to occur on NASDAQ.

What does the Rule 144 filer represent about CFLT’s non-public information?

By signing the notice, the person for whose account the CFLT securities are to be sold represents they do not know any material adverse, non-public information about the issuer’s current or prospective operations that has not already been publicly disclosed.